08.08 12:01 | dpa-AFX: Gilead Sciences Q2 24 Earnings Conference Call At 4:30 PM ET |
30.07 10:19 | dpa-AFX: Biotech Stocks Facing FDA Decision In August 2024 |
29.07 10:15 | dpa-AFX: Biotech Stocks Facing FDA Decision In August 2024 |
25.07 16:40 | dpa-AFX: Gilead's New Data Reinforce Biktarvy As Long-Term HIV Treatment Option; Stock Up |
25.07 15:22 | dpa-AFX: *GILEAD: NEW 5-YEAR DATA REINFORCE BIKTARVY AS LONG-TERM HIV TREATMENT OPTION |
24.07 20:48 | dpa-AFX: Gilead's Twice-yearly Injection Offers 100% Protection Against HIV In Women: Study |
24.07 12:08 | dpa-AFX: Gilead Sciences Reports New Efficacy, Safety Results From Lenacapavir Trial For HIV Prevention |
24.07 10:43 | dpa-AFX: *GILEAD SCIENCES ANNOUNCES FULL EFFICACY AND SAFETY RESULTS FROM PHASE 3 PURPOSE 1 TRIAL |
23.07 20:49 | dpa-AFX: Researchers Suggest That A Costly New HIV Drug By Gilead Could Cost As Little As $40 |
22.07 10:10 | dpa-AFX: *GILEAD AND THE ELTON JOHN AIDS FOUNDATION ANNOUNCE ADDITIONAL FIVE YEARS OF RADIAN PARTNERSHIP |
17.07 16:01 | dpa-AFX: Gilead Sciences Chief Medical Officer Merdad Parsey To Resign |
17.07 15:21 | dpa-AFX: *GILEAD SCIENCES CHIEF MEDICAL OFFICER MERDAD PARSEY TO STEP DOWN |
21.06 22:10 | MÄRKTE USA/Knapp behauptet am Hexensabbat |
21.06 18:26 | MÄRKTE USA/Wall Street stabilisiert sich |
21.06 15:40 | MÄRKTE USA/Wall Street startet vor Daten verhalten |
21.06 14:56 | MÄRKTE USA/Wall Street vor verhaltenem Beginn |
21.06 13:15 | dpa-AFX: Pre-market Movers: SRPT, KAVL, BRNS, SLDB, MOLN. |
20.06 14:55 | dpa-AFX: *GILEAD'S LENACAPAVIR SHOWS 100% EFFICACY IN HIV PREVENTION FOR CISGENDER WOMEN IN PHASE 3 TRIAL |
05.06 08:58 | dpa-AFX: Gilead Announces Long-term Safety And Efficacy Data For Seladelpar In Primary Biliary Cholangitis |
05.06 08:19 | dpa-AFX: *GILEAD SCIENCES' SELADELPAR SHOWS LONG-TERM EFFICACY, SAFETY IN PRIMARY BILIARY CHOLANGITIS |
|